Covid vaccine update: Lawsuits, probe shroud AstraZeneca vaccine trial in India over volunteer's illness
4 years, 1 month ago

Covid vaccine update: Lawsuits, probe shroud AstraZeneca vaccine trial in India over volunteer's illness

India Today  

A 40-year-old volunteer, who was part of the third phase of clinical trial of the coronavirus vaccine being developed by AstraZeneca and Serum Institute of India and is undergoing trials in India, has claimed he suffered neurological symptoms following the dosage. While the volunteer has sent a legal notice to the vaccine makers and sought Rs 5 crore damages, SII has filed a defamation case and sought Rs 100 crore in damages. Indian volunteer seeks damages from AstraZeneca The AstraZeneca coronavirus vaccine is undergoing trials in India in its partnership with the Pune-based SII. A legal notice has been sent to Director General, ICMR, Drugs Controller General of India, Central Drugs Standard Control Organisation, CEO, AstraZeneca UK, Professor Andrew Pollard, Chief Investigator, Oxford Vaccine Trial and Vice-Chancellor of Sri Ramachandra Higher Education and Research. Speaking to India Today TV, a senior official at SII Pune hit back at the volunteer and said, "The drug controller office and health ministry office do not have any problem with the Serum vaccine as they know that the claims made by Chennai-based volunteer is not genuine.” Refuting the allegations as baseless, SII has sued the volunteer for Rs 100 crore in a defamation suit.

India Volunteer Trial Chennai Crore Vaccine Moderna Damages Rs 5 Million Doses 100 Crore Sii  crore  trial  rs  illness  volunteer  lawsuits  sii  shroud  probe  volunteers  million  doses  india  covid  damages  update  vaccine

History of this topic

Covishield Side Effects: Doctors' Group Urges Govt to Review All Covid Vaccines
7 months, 4 weeks ago

Covishield Side Effects: Doctors' Group Urges Govt to Review All Covid Vaccines

News 18  

In the wake of pharmaceutical giant AstraZeneca admitting in a UK court that its Covid vaccine can cause blood clots in rare cases, a group of doctors on Thursday expressed deep concern over the safety of the Covishield vaccine manufactured by the Serum Institute of India. At a press conference, the doctors, under the banner of the Awaken India Movement, …

AstraZeneca withdraws Covishield pointing to low demand, but did rare side effects also play a role?
8 months ago

AstraZeneca withdraws Covishield pointing to low demand, but did rare side effects also play a role?

The Hindu  

Published : May 09, 2024 13:21 IST - 3 MINS READ The pharmaceutical giant AstraZeneca has reportedly withdrawn its COVID-19 vaccine Vaxzevria, also known as Covishield, worldwide, citing commercial reasons for the decision. Vaxzevria saved millions of lives AstraZeneca, who developed the vaccine with Oxford University, said it was “incredibly proud of the role Vaxzevria played in ending the global …

AstraZeneca's Covishield Showed Lowest Incidence of Side Effects in India Versus Globally, Says Top Govt Official
8 months ago

AstraZeneca's Covishield Showed Lowest Incidence of Side Effects in India Versus Globally, Says Top Govt Official

News 18  

AstraZeneca’s vaccine has demonstrated the lowest incidence of side effects in India compared to the global average, a top government official involved in the national roll-out of Covid-19 vaccination told News18. “But only around 50 cases witnessed Thrombosis with Thrombocytopenia Syndrome — a rare side effect caused by the jab — of the 180 crore doses administered against 4 to …

After AstraZeneca covid-19 vax recall worldwide, Serum says it stopped manufacturing jabs in Dec 2021
8 months ago

After AstraZeneca covid-19 vax recall worldwide, Serum says it stopped manufacturing jabs in Dec 2021

Live Mint  

New Delhi: The Serum Institute of India on Wednesday said it has stopped making and supplying covid-19 vaccine Covishield after AstraZeneca, the British drugmaker that helped develop the vaccine, announced it too was withdrawing its version of the jab worldwide. The development follows the launch of a class action suit in the UK over allegations that the UK vaccine caused …

Stopped manufacturing Covishield since December 2021, says Serum Institute
8 months ago

Stopped manufacturing Covishield since December 2021, says Serum Institute

Hindustan Times  

Pune-based Serum Institute of India stopped manufacturing its anti-Covid-19 vaccine Covishield in 2021, according to a statement issued by the company on Wednesday after British-Swedish pharmaceutical manufacturer AstraZeneca announced it was withdrawing its vaccine against Covid, Vaxzevria, due to “commercial reasons” as demand for it decreased globally. Consequently, since December 2021, we have stopped the manufacturing and supply of additional …

AstraZeneca pulls its COVID-19 vaccine from the European market
8 months ago

AstraZeneca pulls its COVID-19 vaccine from the European market

Associated Press  

LONDON — The pharma giant AstraZeneca has requested that the European authorization for its COVID-19 vaccine be pulled, according to the EU medicines regulator. In an update on the European Medicines Agency’s website Wednesday, the regulator said that the approval for AstraZeneca’s Vaxzevria had been withdrawn “at the request of the marketing authorization holder.” AstraZeneca’s COVID-19 vaccine was first given …

AstraZeneca removes its Covid vaccine worldwide after rare and dangerous side effect linked to 80 deaths in Britain was admitted in court papers
8 months ago

AstraZeneca removes its Covid vaccine worldwide after rare and dangerous side effect linked to 80 deaths in Britain was admitted in court papers

Daily Mail  

AstraZeneca is removing its Covid vaccine worldwide, months after the pharmaceutical giant admitted that it can cause a rare and dangerous side effect. The vaccine, once heralded as a 'triumph for British science', has come under intense scrutiny in recent months for a very rare side effect causing blood clots and low blood platelet counts. The AstraZeneca jab was the …

Covishield: Gujarat Cong Demands Compensation, BJP Claims Heart Attacks Not Linked to Vaccine
8 months, 1 week ago

Covishield: Gujarat Cong Demands Compensation, BJP Claims Heart Attacks Not Linked to Vaccine

News 18  

The opposition Congress on Wednesday alleged that the BJP government at the centre did not follow the guidelines of the World Health Organisation, and demanded that the relatives of those who died due to heart attack or similar reasons after taking the Covishield vaccine against coronavirus should be paid compensation. Doctors associated with the Gujarat BJP, however, said a study …

Only 7 Out 10 Lakh May Face Clotting Risk Due to Covishield: Former ICMR Scientist
8 months, 1 week ago

Only 7 Out 10 Lakh May Face Clotting Risk Due to Covishield: Former ICMR Scientist

News 18  

Only seven to eight individuals out of 10 lakh, who receive the coronavirus vaccine Covishield, face the risk of experiencing a rare side effect known as thrombosis thrombocytopenia syndrome. India’s top epidemiologist, former ICMR scientist Dr Raman Gangakhedkar, said those who got this vaccine have “no risk at all”. Gangakhedkar, who is known for his simplistic approach to clearing complicated …

AstraZeneca reaffirms Covid vaccine safety amid rare side effect concerns
8 months, 1 week ago

AstraZeneca reaffirms Covid vaccine safety amid rare side effect concerns

India TV News  

In response to recent concerns regarding potential rare side effects associated with the AstraZeneca-Oxford COVID-19 vaccine, the pharmaceutical company has underscored its unwavering commitment to patient safety while affirming the vaccine's overall safety profile. This comes in the wake of a recent admission by AstraZeneca, the pharmaceutical company, that its Covid vaccine Covishield and Vaxzevria "can, in very rare cases, …

With State prod, India can be world leader in vaccines
11 months, 2 weeks ago

With State prod, India can be world leader in vaccines

Hindustan Times  

The World Health Organization activated its incident management support team as part of its emergency response framework on the emergence of a cluster of atypical pneumonia cases emerging from Wuhan, China, on January 1, 2020. India, the dark horse in the vaccine race, did the unexpected and against all odds, approving EUA to two vaccines — “made in India” Covishield …

Over 220 crore COVID vaccine doses administered across India, but less than 23 crore booster doses: Health Ministry data
1 year ago

Over 220 crore COVID vaccine doses administered across India, but less than 23 crore booster doses: Health Ministry data

The Hindu  

A total of 220.67 crore COVID vaccine doses have been administered across the country as on December 21 this year, according to data released by the Health Ministry on Wednesday. However, only 22.88 crore precautionary or booster doses have been administered across the country among the eligible adult population. Despite the recent increase of people infected with the JN.1 COVID …

EU countries destroyed €4 billion worth of Covid-19 vaccines, reveals research
1 year ago

EU countries destroyed €4 billion worth of Covid-19 vaccines, reveals research

Firstpost  

Governments, including the EU’s second-most populous country France, have been reluctant to reveal the scale of the waste, but it is certain that most EU nations have resorted to wasting doses of the Covid-19 vaccine, once a much sought after commodity Nearly 215 million doses of Covid-19 vaccines purchased by EU countries at the height of the pandemic have since …

COVID-19 Update: India records 260 new cases, total active at 1,828
1 year ago

COVID-19 Update: India records 260 new cases, total active at 1,828

Live Mint  

India reported 260 new cases of COVID-19, with active cases rising to 1,828, as per the latest data from the Union Health Ministry on December 18. Centre Urges States to Heighten Vigilance The central government has written to states and union territories, urging them to maintain "continuous vigilance" in light of the recent surge in COVID-19 cases and the identification …

AstraZeneca strikes £880m deal to buy US vaccine maker amid questions over Covid jab
1 year ago

AstraZeneca strikes £880m deal to buy US vaccine maker amid questions over Covid jab

The Telegraph  

Iskra Reic, executive vice president of vaccines and immune therapies at AstraZeneca, said: “This aligns with our strategy to deliver a portfolio of therapies to address high unmet needs in infectious diseases, and our ambition to protect the most vulnerable patients who have high risk of severe outcomes.” Shares in AstraZeneca rose 1.3pc in afternoon trade on news of the …

The Vaccine War: A tale of Indian scientists' triumph over COVID-19 amid the Left's propaganda to undermine indigenous vaccine
1 year, 3 months ago

The Vaccine War: A tale of Indian scientists' triumph over COVID-19 amid the Left's propaganda to undermine indigenous vaccine

Op India  

Recalling the dreadful chapters from the year 2020 when the spread of novel coronavirus in India killed several lives, affected many businesses, and derailed the normal routine lives of almost all is difficult. But Vivek Ranjan Agnihotri, the marvellous director who earlier amazed audiences with movies like ‘The Kashmir Files’ and ‘The Tashkent Files’ has made an attempt to bring …

Should you get the new COVID booster? The CDC is about to decide
1 year, 3 months ago

Should you get the new COVID booster? The CDC is about to decide

LA Times  

A nurse prepares a syringe of a COVID-19 vaccine. The CDC’s vaccine advisors will soon decide whether to recommend the latest COVID-19 boosters only for frail, older, sick and immunocompromised people or to offer it to everyone over 6 months of age. “I don’t plan to get it myself,” said Dr. Paul Offit, the director of the Vaccine Education Center …

A new regime: On the Emergency Use Authorisation regime in India and clinical trials
1 year, 6 months ago

A new regime: On the Emergency Use Authorisation regime in India and clinical trials

The Hindu  

Last week, the Drug Controller General of India cleared, under the provisions of ‘emergency use authorisation’, a new mRNA vaccine for COVID-19 developed by Pune-based Gennova Biopharmaceuticals, a pioneer in India in developing mRNA vaccines. More than evidence-based assessment, it was a technicality in India’s ‘New Drugs and Clinical Trials Rules, 2019’ that allowed EUA in India for COVID-19 vaccines. …

India-made mRNA vaccine priced at ₹2,292, will be available as a booster dose
1 year, 6 months ago

India-made mRNA vaccine priced at ₹2,292, will be available as a booster dose

The Hindu  

India’s first indigenously developed mRNA vaccine against the dominant Omicron variant of the COVID-19 coronavirus will cost ₹2,292, Sanjay Singh, CEO, Gennova Biopharmaceuticals, said at a press conference on June 24. The vaccine will for now only be available as a booster or “precaution dose”, that is, somebody who has already been vaccinated thrice will be ineligible as the relevant …

India reports 95 new covid cases in a day
1 year, 6 months ago

India reports 95 new covid cases in a day

Live Mint  

New Delhi: India added 95 fresh coronavirus infections in the last 24 hours, while active cases fell to 1,784, according to an update by the health ministry on Wednesday.Tally of reported cases is now 4.5 crore, while death toll stands at 531,898. Covid cases have declined over the last three months after a surge in infections due to XBB.1.16 Omicron …

Axed Covid vaccine contract cost taxpayers £358m
1 year, 6 months ago

Axed Covid vaccine contract cost taxpayers £358m

The Independent  

Get the free Morning Headlines email for news from our reporters across the world Sign up to our free Morning Headlines email Sign up to our free Morning Headlines email SIGN UP I would like to be emailed about offers, events and updates from The Independent. Read our privacy policy A biotechnology company which had its contract to make Covid …

At 14,493, India records sharp dip in daily Covid tally, logs 801 new cases
1 year, 7 months ago

At 14,493, India records sharp dip in daily Covid tally, logs 801 new cases

Hindustan Times  

India has logged 801 new coronavirus infections, while the active cases have dipped to 14,493 from 15,515, according to the Union Health Ministry data updated on Monday. According to the ministry's website, 220.66 crore doses of Covid vaccine have been administered in the country so far under the nationwide vaccination drive. The active cases now comprise 0.03 per cent of …

Serum Institute of India to produce 5mn Covishield doses in two months
1 year, 8 months ago

Serum Institute of India to produce 5mn Covishield doses in two months

Hindustan Times  

Serum Institute of India chief executive officer Adar Poonawalla, while underlining that the current strain of Covid is mild and the demand for vaccine shots is low, said his firm will produce five to six million Covishield doses in the next two to three months and same amount of stock is already available for Covovax. According to Poonawalla, SII has …

WATCH: SII chief Adar Poonawalla on vaccine availability, current Covid strain
1 year, 8 months ago

WATCH: SII chief Adar Poonawalla on vaccine availability, current Covid strain

Hindustan Times  

Commenting on the recent spike in Covid cases countrywide, Serum Institute of India chief executive officer Adar Poonawalla on Saturday said that the current variant of the virus is not severe and five to six million doses of Covovax are available. We will also produce the same amount of Covishield doses in the next two to three months,” news agency …

India logs 9,111 new coronavirus infections, active cases climb to 60,313
1 year, 8 months ago

India logs 9,111 new coronavirus infections, active cases climb to 60,313

Deccan Chronicle  

New Delhi: India recorded 9,111 new coronavirus infections, while the active cases increased to 60,313, according to the Union Health Ministry data updated on Monday.The death toll increased to 5,31,141 with 27 deaths. The daily positivity was recorded at 8.40 per cent and the weekly positivity rate was pegged at 4.94 per cent. The active cases now comprise 0.13 per …

Covid-19: India Reports Close to 11k Fresh Cases Again, Active Tally Exceeds 53,000
1 year, 8 months ago

Covid-19: India Reports Close to 11k Fresh Cases Again, Active Tally Exceeds 53,000

News 18  

India logged a total of 10,753 fresh Covid-19 cases in the past 24 hours, taking the number of active infections to 53,720, the Union Health Ministry data said on Saturday. As per the Ministry’s latest data, the death toll has also climbed to 5,31,091 with 27 deaths recorded in the last 24 hours. This includes six deaths recorded in Delhi, …

India restarts Covid vaccine production as new infections soar 30% in one day
1 year, 8 months ago

India restarts Covid vaccine production as new infections soar 30% in one day

The Independent  

India is ramping up its vaccine production following a rapid surge in Covid-19 cases driven by a new subvariant dubbed Arcturus. The country recorded 10,158 news Covid cases on Thursday, a 30 per cent surge in one day, according to the federal health ministry data. The company stopped manufacturing Covishield in December 2021 due to dwindling demand and a low …

Serum Institute could resume Covishield production as Covid cases rise
1 year, 8 months ago

Serum Institute could resume Covishield production as Covid cases rise

Live Mint  

The Serum Institute of India could resume production of the Covishield Covid-19 vaccine as infections rise in the country, a company spokesperson said on Wednesday. Dr Amitav Banerjee - an epidemiologist who leads DY Patil Medical College in Pune has earlier said that Covishield carried a ‘double whammy of risk’. Many would perhaps not know that Covishield carries a DNA …

Active COVID-19 cases in India rise to 21,179
1 year, 9 months ago

Active COVID-19 cases in India rise to 21,179

The Hindu  

India logged 3,038 new coronavirus cases, while the active cases increased to 21,179, according to the Union Health Ministry data updated on Tuesday, April 4, 2023. The COVID-19 case tally was recorded at 4.47 crore The active cases now comprise 0.05 per cent of the total infections and the national COVID-19 recovery rate was recorded at 98.76 per cent, the …

India witnesses 3,016 fresh COVID-19 cases, highest in nearly six months
1 year, 9 months ago

India witnesses 3,016 fresh COVID-19 cases, highest in nearly six months

Deccan Chronicle  

New Delhi: India saw a single-day rise of 3,016 fresh coronavirus cases, the highest in nearly six months, while the active cases increased to 13,509, according to the Union health ministry data updated on Thursday. According to the ministry data updated at 8 am, the daily positivity was recorded at 2.73 per cent, while the weekly positivity was pegged at …

'Force to Reckon With in Near Future': Ex-ICMR DG Praises Govt’s 'Deliberate' Call to Give Free Covid Jabs
1 year, 9 months ago

'Force to Reckon With in Near Future': Ex-ICMR DG Praises Govt’s 'Deliberate' Call to Give Free Covid Jabs

News 18  

It was the Narendra Modi government’s deliberate and concerted decision to deliver free Covid-19 vaccines to everyone in India unlike other countries where vaccines were sold at exorbitant prices, Dr Balram Bhargava, former director general of Indian Council of Medical Research, has said. “The issue of the pricing of vaccines in India was a deliberate effort of the government to …

India records 1,300 new Covid cases, highest in 140 days
1 year, 9 months ago

India records 1,300 new Covid cases, highest in 140 days

Hindustan Times  

India on Thursday recorded a single-day rise of 1,300 new Covid cases, the highest in 140 days, while the active cases have increased to 7,605, news agency PTI reported quoting Health ministry data. The death toll inched to 5,30,816 with three deaths, one each being reported by Karnataka, Gujarat and Maharashtra, the health ministry data revealed. Former AIIMS director answers …

Active COVID-19 cases in country climb to 7,026
1 year, 9 months ago

Active COVID-19 cases in country climb to 7,026

The Hindu  

India recorded 1,134 new coronavirus cases, while the active cases increased to 7,026, according to the Union Health Ministry data updated on March 22. The death toll climbed to 5,30,813 with five deaths with one each reported by Chhattisgarh, Delhi, Gujarat and Maharashtra and one reconciled by Kerala, the data updated at 8 am stated. The active cases now comprise …

India records 1,134 new Covid cases, active tally crosses 7,000 mark
1 year, 9 months ago

India records 1,134 new Covid cases, active tally crosses 7,000 mark

Hindustan Times  

India on Wednesday recorded a single-day rise of 1,134 new Covid cases, with the active case tally surpassing the 7,000 mark, news agency PTI reported quoting Health ministry data. The rise in Covid cases was attributed to the sudden change in season and people not taking the booster vaccine shot. The number of active cases has increased to 7,026, comprising …

‘The Vial’ trailer out: Manoj Bajpayee narrates History TV18's documentary on India’s Covid-19 vaccine journey
1 year, 9 months ago

‘The Vial’ trailer out: Manoj Bajpayee narrates History TV18's documentary on India’s Covid-19 vaccine journey

Firstpost  

India’s Covid-19 vaccination programme has proven to be the world’s largest but how did the nation, led by Prime Minister Narendra Modi, embark on this journey? To find out the details of a historic and unprecedented battle, check out History TV18’s documentary titled ‘The Vial – India’s Vaccine Story’ on March 24, 2023, at 8PM. ‘The Vial’ brings to life …

India records over 300 new Covid cases after 97 days
1 year, 10 months ago

India records over 300 new Covid cases after 97 days

Hindustan Times  

India logged more than 300 fresh coronavirus cases after 97 days, while the active cases increased to 2,686, according to the Union health ministry data updated on Saturday. The country's infection tally stands at 4.46 crore The country saw a single-day rise of 334 new cases, while the death toll rose to 5,30,775 with three latest fatalities -- two reported …

India saved 3.4mn people through Covid-19 vaccination drive: Report
1 year, 10 months ago

India saved 3.4mn people through Covid-19 vaccination drive: Report

Hindustan Times  

India saved at least 3.4 million lives by undertaking a nationwide Covid-19 vaccination campaign at an unprecedented scale, said a new report released by the Union health minister, Mansukh Mandaviya, on Friday, adding that the vaccination campaign also yielded a positive economic impact by preventing a loss of $18.3 billion. India started its Covid vaccination drive on January 16, 2021, …

Sliding vaccine sales, new costs, squeeze Moderna 4Q profit
1 year, 10 months ago

Sliding vaccine sales, new costs, squeeze Moderna 4Q profit

Associated Press  

Moderna’s fourth-quarter profit tumbled 70% as COVID-19 vaccine sales fell and the drugmaker caught up on a royalty payment. Heavy research and development costs also weighed on Moderna as the vaccine developer looks to strengthen an income statement currently dominated by its Spikevax coronavirus preventive shots. Researchers are testing how Moderna’s potential vaccine and Merck’s immunotherapy Keytruda work in improving …

COVID-19: 3 lakh doses of intranasal vaccine iNCOVACC sent to hospitals, says Bharat Biotech's Krishna Ella
1 year, 11 months ago

COVID-19: 3 lakh doses of intranasal vaccine iNCOVACC sent to hospitals, says Bharat Biotech's Krishna Ella

India TV News  

COVID-19 vaccine : Bharat Biotech dispatched three lakh doses of its intranasal COVID-19 vaccine to some hospitals two days ago, the company's executive chairman Krishna Ella said on Sunday. "We dispatched three lakh doses of the world's first intranasal COVID-19 vaccine to some hospitals two days ago," Ella said. Establishing the UW-Madison Global One Health Centre holds great significance as …

COVID-19: Health Minister Mansukh Mandaviya to launch world's 1st 'Made-in-India' nasal vaccine today
1 year, 11 months ago

COVID-19: Health Minister Mansukh Mandaviya to launch world's 1st 'Made-in-India' nasal vaccine today

India TV News  

COVID-19 nasal vaccine launch : Union Health Minister Dr Mansukh Mandaviya will launch 'iNCOVACC', the world's first made-in-India nasal vaccine on Thursday, official sources said. According to the sources, Hyderabad-based Bharat Biotech's Intranasal heterologous booster dose is likely to be available in the market by February first week.Recently, Bharat Biotech announced iNCOVACC® as a booster dose in the country.Earlier this …

First Indian intranasal Covid vaccine by Bharat Biotech to be launched on Jan 26
1 year, 11 months ago

First Indian intranasal Covid vaccine by Bharat Biotech to be launched on Jan 26

India TV News  

Homegrown vaccine maker Bharat Biotech will launch its intranasal COVID-19 vaccine iNCOVACC, the first of its kind in India, on January 26, the company's chairman and managing director Krishna Ella said here on Saturday. In December, Bharat Biotech had announced that it would sell the intranasal vaccine for Rs 325 per shot for procurement by the government and Rs 800 …

Pfizer CEO Cornered at Davos, India Saw Through Pharma Giant’s Promises Early to Not Bank on it
1 year, 11 months ago

Pfizer CEO Cornered at Davos, India Saw Through Pharma Giant’s Promises Early to Not Bank on it

News 18  

Pfizer CEO Albert Bourla being quizzed at Davos by journalists about the company’s Covid-19 vaccine has triggered the BJP to take on top Congress and AAP leaders for earlier pushing for the Pfizer shot to be brought to India. But facts show that not only was the vaccine offered by Pfizer and Moderna exorbitantly priced at over $20 for each …

Covid-19: Active Cases in Country Dip to 2,149
1 year, 11 months ago

Covid-19: Active Cases in Country Dip to 2,149

News 18  

India logged 104 new coronavirus infections, while the active cases declined to 2,149, according to the Union Health Ministry data updated on Sunday. The active cases comprises 0.01 per cent of the total infections, while the national COVID-19 recovery rate increased to 98.80 per cent, according to the ministry website. According to the ministry’s website, 220.17 crore doses of Covid …

100 Cr Defamation Suit | 'People Responsible For Saving Four Million Lives Being Branded As Mass Murderers': Serum Institute To Bombay High Court
1 year, 11 months ago

100 Cr Defamation Suit | 'People Responsible For Saving Four Million Lives Being Branded As Mass Murderers': Serum Institute To Bombay High Court

Live Law  

Four million lives have been saved using vaccines, Covishield manufacturer Serum Institute of India told the Bombay High Court on Friday while responding to allegations that the vaccine is harmful. 100 crore defamation suit filed by SII and its CEO Adar Poonawala against a social media influencer and another individual and restrain them from posting defamatory content against the company. …

COVID-19: Covovax vaccine to get approval as booster dose in 10-15 days, says Poonawalla
2 years ago

COVID-19: Covovax vaccine to get approval as booster dose in 10-15 days, says Poonawalla

Firstpost  

Pune: Chief Executive Officer of Serum Institute of India, Adar Poonawalla, has said their Covovax vaccine will get approval as a booster dose against Covid-19 in the next 10 to 15 days. Poonawalla told the media that the vaccine works very well against the Omicron variant of coronavirus. Speaking to reporters on the sidelines of an event at the Bharati …

214 Fresh Covid-19 Cases, 4 Deaths in Last 24 Hours
2 years ago

214 Fresh Covid-19 Cases, 4 Deaths in Last 24 Hours

News 18  

India on Saturday recorded 214 fresh coronavirus infections, while the number of active cases increased marginally to 2,509, according to Union health ministry data. The weekly positivity rate stood at 0.12 per cent, according to the health ministry website. The active cases comprise 0.01 per cent of the total infections, while the national COVID-19 recovery rate has increased to 98.80 …

No second Covid-19 booster dose required: Report
2 years ago

No second Covid-19 booster dose required: Report

Live Mint  

There is no need to take a second booster dose against Covid-19 infection, news agency ANI reported on Tuesday citing government sources. According to the data by the Union Health Ministry, a total of 220.11 crore vaccine doses have been administered in the country, of which 95.13 crore have taken the second dose while only 22.41 crore of the population …

Biological E, Bharat Biotech Together Sitting on Stockpile of 250 Million Covid Vaccine Doses
2 years ago

Biological E, Bharat Biotech Together Sitting on Stockpile of 250 Million Covid Vaccine Doses

News 18  

Two major vaccine makers from Hyderabad, Biological E Ltd and Bharat Biotech, together are holding about 250 million doses of Covid-19 vaccines ready to dispatch as and when orders are received. According to respective company sources, Biological E is holding 200 million doses of its Covid-19 vaccine Corbevax while Bharat Biotech is sitting on a stockpile of 50 million doses …

Biological E, Bharat Biotech have stockpile of 250 million COVID vaccine doses
2 years ago

Biological E, Bharat Biotech have stockpile of 250 million COVID vaccine doses

India TV News  

As Covid cases are increasing in the country, now focus is back on vaccination drive. According to sources- two major vaccine makers from Hyderabad, Biological E Ltd and Bharat Biotech, together have about 250 million doses of COVID-19 vaccines ready to dispatch as and when orders are received. Corbevax and Covaxin stocks Biological E held 200 million doses of its …

Staying prepared: On scaling up the pace of COVID-19 genome sequencing
2 years ago

Staying prepared: On scaling up the pace of COVID-19 genome sequencing

The Hindu  

Three years after strict enforcement of its Zero-COVID strategy, China abandoned it abruptly, leading to a jump in cases each day — an estimated 250 million people were infected in 20 days in December, according to the media, overwhelming hospitals and crematoria. Though this variant was found in many countries, including India, months ago, there is fear that the uncontrolled …

Discover Related